Smoking cessation self-efficacy and adaptive coping are posited as 2 important treatment targets in smoking cessation interventions, especially in the context of handling strong urges to smoke. Yet, less is known about whether intervention-related changes in these constructs predict long-term smoking outcomes. The current study aimed to examine changes in smoking urges, smoking cessation selfefficacy, and adaptive coping after a health-focused and cognitive-behavioral telephone-delivered smoking cessation treatment, and the association to smoking reduction during long-term, 12-month follow-up.
Participants (n = 61) were daily smokers enrolled in a 12-week pilot trial that tested the efficacy of 2 different health-focused interventions with an adjunct of traditional telephone-delivered cessation counseling. Smoking urges, smoking cessation self-efficacy, and adaptive coping were assessed as baseline and immediately posttreatment. An average of 7-day cigarettes use per day were assessed at posttreatment, and 6 and 12 months postbaseline follow-up timepoints.
Results:
Smoking urges were significantly lower posttreatment, and smoking cessation self-efficacy and adaptive coping were significantly higher posttreatment, relative to baseline. After adjusting for baseline values, posttreatment smoking urges were significantly positively associated with cigarette use at posttreatment and 6-month follow-up. Posttreatment smoking cessation self-efficacy, but not adaptive coping, was significantly negatively predictive of cigarette use at posttreatment and 6and 12-month follow-up timepoints. Posttreatment smoking cessation self-efficacy emerged as significant indirect predictor of the association between posttreatment smoking urges and posttreatment cigarette use.
Conclusions:
Interventions that target smoking cessation self-efficacy may facilitate long-term reductions in smoking among daily smokers undergoing a quit attempt.
Key Words: tobacco, relapse prevention, coping skills (Addict Disord Their Treatment 2016; 15:183-189) C igarette smoking remains the leading cause of preventable death and illness in the United States, 1 as 16.8% smoke. 2 The monetary cost of tobacco use is approximated to exceed $300 billion. 1 It is well documented that multiple problematic health behaviors frequently co-occur with cigarette smoking, including other substance use and physical inactivity, [3] [4] [5] [6] which in part may compound risk for early mortality and morbidity. 7 Rates of relapse to cigarette use among individuals initiating a quit attempt are high, particularly within the first 5 to 10 days after quit date. 8 Thus, smoking cessation protocols that incorporate support leading up to and following quit date may be especially efficacious in reducing rates of relapse to smoking. Factors such as nicotine withdrawal, craving, and urge are predictors of early smoking relapse. 9 There is a need to examine factors that may increase long-term efficacy of smoking cessation treatments.
Theoretical models of relapse prevention 10, 11 posit that a return (lapse, relapse) to substance use results from low perceived ability to abstain from use (abstinence self-efficacy) and limited adaptive coping strategies in the context of high-risk situations (eg, strong urges to use). This theoretical model has been supported in a variety of studies with diverse populations and substances. [12] [13] [14] [15] [16] Specific to cigarette use, urge/craving is one of the most consistent predictors of relapse to reinitiation of smoking. 8 Various smoking cessation treatment programs have been developed to specifically bolster certain cognitive and behavioral skills to promote smoking cessation-including smoking cessation self-efficacy and coping skills, especially in the context of strong smoking urges/craving. 17, 18 Data indicate that relapse preventionbased smoking cessation protocols increase self-efficacy for abstaining from cigarette use across a variety of situations, 19 and smoking cessation self-efficacy is among the strongest predictors of smoking abstinence, 20,21 particularly among those initiating a quit attempt. 22 Smoking cessation self-efficacy has also been found to explain (mediate) the link between craving and smoking outcomes. 23 Greater adaptive coping skills are also associated with positive smoking cessation treatment outcomes. 24, 25 For example, the stress and coping model describes adaptive coping as a method to attenuate the impact of stress and decrease the potential for negative outcomes, such as a lapse or relapse. 26 Previous studies have examined the role of self-efficacy in smoking cessation, 21 but the current study adds to the literature by examining how smoking urges are related to smoking self-efficacy and adaptive coping to predict smoking cessation outcomes.
Utilizing intervention trial data from Abrantes et al, 27 the current study aimed to (a) examine changes in smoking urges, smoking cessation self-efficacy, and adaptive coping postsmoking cessation intervention, and (b) test whether these changes in smoking cessation selfefficacy and adaptive coping attenuate the relationship between urge and cigarette use posttreatment and at long-term follow-up. Specifically, the following hypotheses were proposed: (1) smoking urges will be significantly lower posttreatment relative to baseline, and posttreatment smoking urges will be positively associated with greater cigarette use posttreatment and at followup; (2) smoking cessation self-efficacy and adaptive coping will be significantly higher at posttreatment, relative to baseline, and posttreatment scores will be associated with lower cigarette use posttreatment and at follow-up; and (3) posttreatment smoking urges will be negatively associated with posttreatment smoking cessation self-efficacy and adaptive coping, which in turn will be negatively associated with posttreatment cigarette use (ie, test of mediation).
METHODS

Participants
Participants (n = 61, M age = 47.3, SD = 9.6, 65.6% women) were recruited as part of a randomized controlled trial of 2 health-focused interventions for sedentary daily smokers. 27 Participants were eligible on the basis of smoking Z10 cigarettes per day for the past year and exercising <60 minutes per week during the previous 6 months before enrollment. Participants were excluded if they had a current contraindicated psychiatric disorder (alcohol/drug use disorder, bipolar disorder, psychotic disorder, or eating disorder; defined by the Diagnostic and Statistical Manual of Mental Disorders), current suicidal ideation or homicidal ideation, a physical or medical issue that would prevent engagement in aerobic exercise (including pregnancy), and current use of pharmacotherapy for smoking cessation. Participants were primarily white (80.3%), smoked an average of 19.7 cigarettes per day at initial screening (SD = 8.6), and reported daily smoking for the past 27.5 years (SD = 10.1). For complete sample details, please see Abrantes et al. 27 
Procedures
Participants were randomized to receive either 12 weeks of an aerobic exercise intervention (n = 30) or 12 weeks of a health education intervention ( n = 31), as detailed in Abrantes et al. 27 All participants received 8 sessions of 20-minute cognitive behavioral-based telephone sessions over the course of 8 weeks, modeled after cessation interventions delivered in previous work. [28] [29] [30] [31] These sessions were designed to prepare participants for their quit date (in week 4) by identifying highrisk situations for cigarette use, developing and utilizing coping strategies, increasing smoking cessation self-efficacy (through practiced reduction of 1 to 2 cigarettes/d before quitting), setting incremental goals, and relapse prevention (on quit day and after 3 wk). All participants also received nicotine replacement therapy (through the transdermal nicotine patch) throughout the course of the study (see Abrantes et al 27 for details on administration). Assessment of smoking behavior and urges, smoking cessation self-efficacy and adaptive coping were assessed via self-report at baseline (pretreatment), immediately posttreatment, and at 2 follow-up timepoints (6 and 12 mo postbaseline). All participants provided written informed consent before participants and all study procedures were approved by the institutional review board of Butler Hospital.
Measures
Cigarette Use
The Timeline Follow-back 32 is as calendar-based assessment of daily cigarette use, which was used to determine the average number of cigarettes smoked per day during the past 7 days before the assessment timepoint. Selfreported point prevalence abstinence (no smoking in the past 7 d) was verified using expired carbon monoxide breath sample (using a 10 ppm cutoff) and/or observer report (significant other), a method that has been validated in previous studies. 27 
Smoking Cessation Self-Efficacy
The Smoking Self-Efficacy Scale 33 is a self-report assessment that requires participants to rate on a scale of 1 (not at all confident) to 5 (extremely confident) their perceived ability to avoid using cigarettes in a variety of situations. Cronbach's a estimates suggested these items had excellent reliability (a = 0.90 at baseline, 0.95 at posttreatment).
Smoking Urges
The Questionnaire of Smoking Urges 34 is a 32-item self-report measure of the intensity of smoking urges (eg, ''Smoking would make me feel very good right now''). Items were rated on a scale of 1 (strongly disagree) to 7 (strongly agree). Reliability estimates were as follows: Cronbach's a = 0.60 at baseline, 0.66 at posttreatment.
Adaptive Coping
The Brief COPE scale 35 is a 28-item measure designed to assess for a variety of coping strategies for stressful or difficult life situations. The measure asks participants how often they utilize various coping strategies during life situations on a scale of 1 (I usually don't do this at all) to 4 (I usually do this a lot). Adaptive coping was assessed through the subscales of active coping, emotional support, instrumental support, planning, acceptance, and positive reframing. Estimates were suggestive of excellent reliability (Cronbach's a = 0.91 at baseline, 0.92 at posttreatment).
RESULTS
Changes in Smoking Urges, Smoking Cessation Self-Efficacy, and Coping
Regression analyses tested the effects of the intervention on smoking urges, smoking cessation self-efficacy, and adaptive coping. Table 1 displays baseline and posttreatment means, across treatment conditions. Results indicated that smoking urges significantly decreased from baseline to posttreatment (b = 0.36, P = 0.02); however, there was no significant time Â condition effect (b = -0.15, P = 0.33). In addition, results indicated that there was a significant increase in smoking cessation self-efficacy from baseline to posttreatment (b = 0.30, P = 0.05, Table 1 ), although the time Â condition interaction was again nonsignificant (b = 0.14, P = 0.35). Similarly, analyses of adaptive coping indicated a significant increase in adaptive coping from baseline to posttreatment (b = 0.57, P<0.01); these results did not significantly differ by condition (b = -0.05, P = 0.69). On the basis of the nonsignificant treatment condition effects in the variables of interest, treatment conditions were collapsed in all subsequent analyses.
Predicting Reductions in Cigarette Use
Next, a series of regression models were constructed to test the role of smoking urges, smoking cessation selfefficacy, and adaptive coping as predictors of cigarette use at posttreatment, and follow-up timepoints (6 and 12 mo postbaseline). In step 1 of each model, baseline number of cigarettes per day was entered as a covariate, in addition to the baseline score on the predictor variable.
Step 2 included the posttreatment of the predictor variable. A total of 9 models were conducted (3 predictors Â 3 timepoints). Model results are presented in Table 2 .
Results from regression analyses revealed that posttreatment smoking urges were significantly (positively) associated with cigarette use at posttreatment and 6-month timepoints, but the effect was nonsignificant at 12 months. In terms of smoking cessation self-efficacy, posttreatment smoking cessation self-efficacy was significantly negatively predictive of cigarette use at posttreatment and at 6-and 12-month follow-up. All models with adaptive coping were nonsignificant.
Analyses of Indirect Effects
A model was constructed to test whether smoking cessation self-efficacy was an indirect predictor of the crosssectional association between posttreatment smoking urges and cigarette use. Analyses were conducted using PROC-ESS, a conditional process modeling macro that tests for both direct and indirect effects using an ordinary least squares-based path analytical framework. 36 The 95-percentile confidence intervals for b indices were obtained analytically, whereas bootstrapping with 5000 resamples was used to estimate confidence intervals for the indirect effects. [37] [38] [39] Figure 1 depicts results from indirect tests, utilizing baseline cigarette use, smoking cessation self-efficacy, and urge as covariates. Results indicated that there was a significant negative association between posttreatment smoking urges and smoking cessation self-efficacy (path a), and a significant negative association between smoking cessation self-efficacy and cigarette use (path b). There was a nonsignificant direct association between posttreatment smoking urges and cigarette use (path c). However, smoking urges were significantly associated with cigarette use indirectly via smoking cessation self-efficacy.
DISCUSSION
The present study investigated the associations between smoking cessation self-efficacy, adaptive coping, smoking urge, and smoking outcomes among daily smokers undergoing a quit attempt who received a health-based intervention plus participated in 8 telephone-delivered cognitive-behavioral smoking cessation sessions. Results indicated that smoking cessation self-efficacy and adaptive coping significantly increased from baseline to posttreatment, whereas smoking urge decreased. In addition, increases in smoking cessation self-efficacy were associated with subsequent reductions in smoking at 3 follow-up periods, and reduction in urge predicted reductions in smoking at the posttreatment and 6month timepoints. Indirect tests revealed that posttreatment urge was associated with use through smoking cessation self-efficacy. Overall, the findings support the importance of smoking cessation self-efficacy in predicting smoking outcomes and suggest avenues for future research.
Throughout the course of the smoking cessation treatment, participants in both conditions (ie, exercise or health education) increased their self-efficacy for abstaining from smoking and adaptive coping strategies while decreasing smoking urge. Both conditions received the same smoking cessation treatment that was designed to help participants set incremental goals toward smoking abstinence and support participants through the course of their quit attempt. These sessions were individualized, focusing on the specific needs of the participant and included practicing coping strategies by reducing 1 to 2 cigarettes per day before the scheduled quit date. It is likely that participants developed a sense of mastery over their cigarette use, thus increasing their confidence in their ability to quit smoking. Results are consistent with theory 40 and are similar to other studies that have examined the role of abstinence self-efficacy in reducing the rates of smoking. 21, 22 In addition, the present study found that the impact of smoking cessation self-efficacy was robust and persisted over the course of a long-term follow-up. Thus, initial gains in smoking cessation selfefficacy during the cessation treatment were related to beneficial smoking outcomes in the long term. The associations with adaptive coping and smoking outcomes were nonsignificant. Although adaptive coping increased from baseline to posttreatment, adaptive coping was not predictive of smoking outcomes. Specific coping strategies for high-risk smoking situations were not assessed: participants were asked broadly about the coping strategies that they utilize for stressful life situations. Thus, it is possible that, although participants were using these strategies, they were not using adaptive coping in smoking-specific situations. Future studies could examine this possibility by prompting participants to respond specifically regarding their coping strategies for smoking-related situations, such as urges and cravings to smoke. Further, it may be advantageous to study these constructs through ecological momentary assessment.
The relations between urges and smoking outcomes were significant via smoking cessation self-efficacy, even when controlling for baseline levels of the constructs. Previous studies have substantiated the role of smoking cessation self-efficacy as a mediator between urge and smoking outcomes, particularly among those with higher rates of negative affect. 23 In other work, postcessation self-efficacy has been shown to mediate the relationship between negative affect-which is commonly associated with the urge to use-and outcomes. 20 All models conducted controlling for baseline cigarettes per day and baseline scores on the predictor measure.
CPD indicates cigarettes per day in the past-7 days; post-TX, posttreatment. treatment may be especially efficacious by building smoking cessation self-efficacy for abstaining from use in times of high urge.
Several limitations should be noted. The study may have lacked power to detect significant findings because of the small sample size. In addition, the sample was primarily white and female. All participants were sedentary smokers. Future studies should evaluate these relationships in a larger, more diverse sample.
CONCLUSIONS
Overall, this study provided promising support for the role of cognitivebehavioral smoking cessation treatment in increasing self-efficacy and adaptive coping while reducing urges to smoke. In particular, self-efficacy seems to be a robust factor that predicts long-term smoking outcomes in cessation treatment. Therefore, initial treatment gains in self-efficacy can play an important role in sustained cessation effects.
